Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
From children's scooters to chainsaws, National Trading Standards has listed some of the potentially dangerous items it seizes daily.
A study by the University of Oxford forecasts an increase of more than half a million foreign-born people in England between 2011 and 2014.
More deprived areas of England have received the biggest cuts over the last five years, according to an influential think-tank.